EU approves Novartis eye drug for new use

ZURICH (Reuters) - Swiss drugmaker Novartis' eye drug Lucentis has been approved as a treatment for a further condition related to worsening eyesight by the European Union, adding to three other conditions for which it is already approved.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news